SmartTest Technologies is an early-stage company developing a comprehensive digital health platform for at-home blood testing, starting with glucose monitoring for the prediabetes market. The company has created Smart-AE, an automated, wireless glucose testing device designed to provide painless, accurate, and real-time results. At the heart of SmartTest’s platform is a patented painless testing mechanism, ensuring ease of use and comfort for users. The system utilizes single-use disposable tests and precision technology to deliver accurate and reliable readings, supporting early detection and proactive health management. The SmartTest digital platform seamlessly integrates with the Smart-AE device, enabling real-time data transmission, personalized health insights, and remote monitoring. Through our mobile app, users can track glucose trends, receive health recommendations, and securely share their results with healthcare providers. This connectivity bridges the gap between home diagnostics and professional medical support, empowering individuals to take control of their health. While SmartTest Technologies is launching with glucose monitoring, the company is expanding its platform to include a broad range of tests, such as lactate, cholesterol, and infectious diseases like HIV. These additional capabilities will further enhance the platform’s role in preventive healthcare, making advanced diagnostics more accessible and efficient. With its integrated digital health approach, SmartTest Technologies is redefining at-home blood testing—delivering a seamless, connected, and user-friendly solution that supports better health outcomes and proactive disease prevention.